CORONNELLO, MARCELLA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.589
EU - Europa 4.152
AS - Asia 2.631
SA - Sud America 268
OC - Oceania 57
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 12.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.541
RU - Federazione Russa 1.281
PL - Polonia 842
SG - Singapore 785
IT - Italia 709
CN - Cina 701
IE - Irlanda 399
HK - Hong Kong 394
SE - Svezia 309
KR - Corea 233
VN - Vietnam 228
BR - Brasile 211
DE - Germania 145
FI - Finlandia 113
UA - Ucraina 109
FR - Francia 98
IN - India 97
GB - Regno Unito 63
AU - Australia 50
JP - Giappone 45
CA - Canada 32
JO - Giordania 29
CH - Svizzera 23
BD - Bangladesh 20
TR - Turchia 20
AR - Argentina 18
ID - Indonesia 18
NL - Olanda 18
ES - Italia 16
EC - Ecuador 15
IQ - Iraq 12
CI - Costa d'Avorio 11
MX - Messico 8
CO - Colombia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CL - Cile 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
ZA - Sudafrica 6
MA - Marocco 5
PH - Filippine 5
PY - Paraguay 5
BJ - Benin 4
CR - Costa Rica 4
LT - Lituania 4
TN - Tunisia 4
CY - Cipro 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
MY - Malesia 3
NP - Nepal 3
PK - Pakistan 3
UZ - Uzbekistan 3
VE - Venezuela 3
AT - Austria 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
SC - Seychelles 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BH - Bahrain 1
CG - Congo 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 12.749
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.451
Warsaw 841
Ashburn 540
Singapore 533
Dublin 398
Fairfield 393
Chandler 329
Hong Kong 315
Seoul 230
Cambridge 193
Woodbridge 181
Houston 168
Jacksonville 167
Beijing 166
Seattle 161
Hefei 153
San Jose 137
Milan 122
Wilmington 122
Florence 98
Buffalo 90
Ann Arbor 77
Ho Chi Minh City 77
Princeton 76
Lauterbourg 70
Mumbai 65
Los Angeles 62
Boston 60
The Dalles 58
Altamura 53
Lawrence 51
Boardman 50
Moscow 50
Melbourne 48
Munich 47
Rome 46
Shanghai 46
Tokyo 44
Dallas 42
Hanoi 39
Council Bluffs 38
Helsinki 36
New York 34
Bern 23
Naples 23
Medford 22
Turin 22
Kent 20
Redondo Beach 20
San Diego 20
Dearborn 19
São Paulo 18
Phoenix 17
Jakarta 15
Dong Ket 14
Turku 14
Bologna 12
Abidjan 11
Clifton 11
Figino 11
Guangzhou 11
Toronto 11
London 10
Norwalk 10
Orem 10
Rio de Janeiro 10
West Jordan 10
Bari 9
Bengaluru 9
Chennai 9
Haiphong 9
Paris 9
Quito 9
Tianjin 9
Andover 8
Da Nang 8
Denver 8
Genoa 8
Izmir 8
Yubileyny 8
Chicago 7
Frankfurt am Main 7
Hillsboro 7
Palermo 7
San Francisco 7
Bremen 6
Brooklyn 6
Brussels 6
Falls Church 6
Miano 6
Montreal 6
Poplar 6
Abuja 5
Atlanta 5
Baghdad 5
Barcelona 5
Redwood City 5
Scandicci 5
Asunción 4
Auburn Hills 4
Totale 8.547
Salva come PNG Salva come JPEG
Nome #
MECHANISMS OF CYTOTOXICITY OF SELECTED ORGANOGOLD(III) COMPOUNDS 385
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents. 363
Solution Chemistry and Cytotoxic Properties of Novel Organogold(III) Compounds 345
Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype 340
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. 337
Pirenoxine prevents oxidative effects of argon fluoride excimer laser irradiation in rabbit corneas: biochemical, histological and cytofluorimetric evaluations. 274
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 244
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 230
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 220
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 214
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 212
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 207
LIPOSOMES LOADED WITH BERBERINE HYDROCHLORIDE: DEVELOPMENT, OPTIMISATION AND IN VITRO CITOTOXICITY 207
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. 201
Aminoarylesters as multidrug resistance (MDR) reverting agents endowed with high potency and efficacy 197
Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR) 192
N,N-bis(alkanol)amine aryl esters and N,N-bis(cyclohexanol)amine aryl esters: Idantification of a new class of Pgp-dependent multidrug resistance (MDR) reverters andowed with potencies in the nanomolar range 181
New dual P-Glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as Multidrug Resistance (MDR) reversers in cancer cells 180
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 177
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 177
P-glycoprotein and carbonic anhydrases hybrid inhibitors: a new strategy to reverse multidrug resistance (MDR) in cancer cells 177
Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. 175
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity 172
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 167
Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression 167
Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. 167
Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulations 165
Alkaline elution of DNA as a method for assessing genotoxic effects of drugs: its application to a series of antiviral compounds. 161
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. 160
Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity and DNA Binding Properties 158
Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells 158
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 152
Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate. 150
Structural and Solution Chemistry, Antiproliferative Effects, and DNA and Protein Binding Properties of a Series of Dinuclear Gold(III) Compounds with Bipyridyl Ligands 149
Analisi cariologica di linee cellulari leucemiche umane CCRF-CEM resistenti al metotressato (MTX) per alterata poliglutammilazione. 147
Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial. 145
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 144
Role of ATP-binding cassette transporters in cancer initiation and progression 144
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. 142
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM. 142
Transferrin-targeted stealth liposomes loaded with artemisinin: The Trojan horse to enhance its selectivity and anticancer activity 141
Synthesis of new pyrazolo[5,1-c][1,2,4]benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4]triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions. 141
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 139
New multidrug resistance (MDR) agents endowed with good potency and efficacy 139
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 139
Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells 136
New dendrimer-based nanoparticles enhance solubility of curcumin. 136
Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors 132
Bacteriological, pharmacokinetic and clinical study of dibekacin 131
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM 130
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides. 129
Modulation of fluoropyrimidine cytotoxicity by methotrexate or5-methyltetrahydrofolate in human leukemia cells in vitro 128
Citotossicità comparativa di metotrexato (MTX) e trimetrexato (TMTX) in cellule leucemiche umane. 127
Liposomes for dihydroartemisinin delivery to cancer cells: development, characterization and in vitro studies. 126
Conventional, stealth and transferrin-conjiugates liposomes for artemisinin delivery to cancer cells. 125
Gold(III) complexes as potential antitumor agents: cytotoxic properties and interaction with DNA of some selected gold(III) compounds 123
Compa¬rative effects of two non-classical antifolates, tri¬metrexate (TMQ) and triazinate (TZT), on 5-fluoroura¬cil (FUra) cytotoxicity against human CCRF-CEM leukemia cells. 120
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 119
Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance 118
Citotossicità comparativa del 3-(p-fluorofenil)-L-alanilmetionina etilestere clori¬drato, PTT-119, e del melfalan (L-PAM) in cellule tu¬morali umane. 116
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 115
Solution chemistry and DNA binding properties of cytotoxic gold(III) complexes. 115
Characterization and selective pharmacologic circumven¬tion of metho¬trexate (MTX) resi¬stance in leukemia cells 113
Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. 112
Isomeric N,N-dicyclohexane-4-ol-amine aryl esters: chemical and pharmacological development of highly potent and efficacious Pgp-dependent MDR inhibitors 111
Unexpected Multidrug Resistance (MDR) reverting activity of a new series of N,N-bis(arylalkanol)amine aryl esters 110
Multidrug Resistance (MDR) reverting agents:structure-activity relationships of a series of N,Nbis(arylalkanol)amine aryl esters 110
Bacteriological, pharmacokinetic and clinical evaluation of bekanamycin 103
Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. 102
Synthesis of functionalised organochalcogenides and in vitro evaluation of their antioxidant activity 102
Effetti di esposizioni alter¬nate a trimetressato (TMTX) e metotres¬sato (MTX) sulla insorgenza di resistenza agli antifolici in un modello di leucemia T-linfoblastica umana (CCRF-CEM) in vitro. 99
Sviluppo di linee cellulari leu¬cemiche umane resistenti al metotres¬sato (MTX). Ri¬sultati preliminari con un modello in studio in vitro alternativo 98
Modulazione dei livelli di mRNA della diidrofolico reduttasi mediante oligonucleotidi antisenso in cellule leucemiche umane (CCRF-CEM/E) con superespressione di questo enzima. 97
Pharmacokinetics of 5-methyltetrahydrofolate in normal adults 92
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 88
Valutazione dell'indice terapeu¬tico in vi¬tro di un vettore liposomiale veicolante metotrexato (MTX) in cellule leucemiche umane CCRF-CEM in immu¬nociti umani nor¬mali. 86
Modulation of fluorodeoxyuridine cytotoxicity in human adenocarcinoma HCT-8 cells by antisense oligonucleotides targeted to thymidylate synthase. 80
Modulation of dihydrofolate reductase (DHFR) mRNA levels in human leukemia CCRF-CEM/E line overexpressing this enzyme by antisense oligodeoxynucleotides. 77
Flow cy¬tometric evaluation of the in¬hibitory effects of li¬posome-entrapped methotrexate (MTX) on lymphocyte proliferation and polymorphonuclear (PMN) leukocyte functions. 74
Polyglutamylation: an essential step in the activation of 5,10-dideazatetrahydrofolic acid (DDATHF) 74
Modulation of fluorodeoxyuridine cytotoxicity in human adenocarcinoma HCT-8 cells by antisense oligonucleotides targeted to thymidylate synthase. 72
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 69
Ultrastructural and chemosensitivity features of primary metastatic melanoma cells: preliminary results. 63
null 52
Totale 12.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022500 20 44 29 33 18 16 14 33 22 16 129 126
2022/20231.430 133 183 89 100 126 273 204 87 151 13 32 39
2023/2024567 25 60 90 25 32 120 25 116 9 28 20 17
2024/20253.748 142 380 210 540 1.121 639 46 155 177 61 132 145
2025/20263.699 458 546 351 245 420 139 397 188 210 192 88 465
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 12.834